Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C120227 |
2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide |
2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide results in decreased activity of MAP2K1 protein | decreases activity | 18393446
|
C120227 |
2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide |
2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide inhibits the reaction [MAP2K1 protein results in increased activity of RPS6KB1 protein] | decreases reaction|increases activity | 12411397
|
C120227 |
2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide |
2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide inhibits the reaction [MAP2K1 protein results in increased phosphorylation of EIF4EBP1 protein] | decreases reaction|increases phosphorylation | 12411397
|
C120227 |
2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide |
2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide results in decreased activity of MAP2K1 protein | decreases activity | 16467208 16261397 16940797
|
C085911 |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [MAP2K1 protein results in increased activity of RPS6KB1 protein] | decreases reaction|increases activity | 12411397
|
C085911 |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [MAP2K1 protein results in increased phosphorylation of EIF4EBP1 protein] | decreases reaction|increases phosphorylation | 12411397
|
C506698 |
2,5-dimethylcelecoxib |
2,5-dimethylcelecoxib inhibits the reaction [IL6 protein results in increased phosphorylation of MAP2K1 protein] | decreases reaction|increases phosphorylation | 16123214
|
C506698 |
2,5-dimethylcelecoxib |
2,5-dimethylcelecoxib results in decreased phosphorylation of MAP2K1 protein | decreases phosphorylation | 16123214
|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of MAP2K1 mRNA | affects expression | 21346803
|
C496751 |
4-(1H-imidazol-1-yl)retinoic acid |
4-(1H-imidazol-1-yl)retinoic acid results in decreased expression of MAP2K1 protein | decreases expression | 17145897
|
C010643 |
6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid |
6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [Vitamin A results in increased phosphorylation of MAP2K1 protein] | decreases reaction|increases phosphorylation | 16510265
|
C072876 |
A 771726 |
A 771726 inhibits the reaction [TNF protein results in increased activity of MAP2K1 protein] | decreases reaction|increases activity | 9973483
|
D000255 |
Adenosine Triphosphate |
Adenosine Triphosphate binds to MAP2K1 protein | affects binding | 17693661
|
C412373 |
AG 1879 |
AG 1879 inhibits the reaction [Vitamin A results in increased phosphorylation of MAP2K1 protein] | decreases reaction|increases phosphorylation | 16510265
|
D013196 |
Dihydrotestosterone |
bicalutamide inhibits the reaction [Dihydrotestosterone results in increased phosphorylation of and results in increased activity of MAP2K1 protein] | decreases reaction|increases activity|increases phosphorylation | 15466214
|
D013196 |
Dihydrotestosterone |
Dihydrotestosterone results in increased phosphorylation of and results in increased activity of MAP2K1 protein | increases activity|increases phosphorylation | 15466214
|
D013196 |
Dihydrotestosterone |
PD 98059 inhibits the reaction [Dihydrotestosterone results in increased phosphorylation of and results in increased activity of MAP2K1 protein] | decreases reaction|increases activity|increases phosphorylation | 15466214
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of MAP2K1 mRNA | affects expression | 16483693
|
D000643 |
Ammonium Chloride |
Ammonium Chloride results in increased expression of MAP2K1 mRNA | increases expression | 12420312
|
C031385 |
anthranilic acid |
anthranilic acid results in decreased activity of MAP2K1 protein | decreases activity | 18393446
|
D017638 |
Asbestos, Crocidolite |
Asbestos, Crocidolite results in increased phosphorylation of MAP2K1 protein | increases phosphorylation | 18314537
|
D017638 |
Asbestos, Crocidolite |
MAP2K1 protein affects the reaction [Asbestos, Crocidolite results in increased expression of SCGB1A1 mRNA] | affects reaction|increases expression | 18192500
|
D017638 |
Asbestos, Crocidolite |
MAP2K1 protein affects the reaction [Asbestos, Crocidolite results in increased phosphorylation of MAPK1 protein] | affects reaction|increases phosphorylation | 18192500
|
D017638 |
Asbestos, Crocidolite |
MAP2K1 protein affects the reaction [Asbestos, Crocidolite results in increased phosphorylation of MAPK3 protein] | affects reaction|increases phosphorylation | 18192500
|
D017638 |
Asbestos, Crocidolite |
MAP2K1 protein inhibits the reaction [Asbestos, Crocidolite results in increased expression of COL1A1 mRNA] | decreases reaction|increases expression | 18192500
|
D017638 |
Asbestos, Crocidolite |
MAP2K1 protein inhibits the reaction [Asbestos, Crocidolite results in increased expression of COL3A1 mRNA] | decreases reaction|increases expression | 18192500
|
D017638 |
Asbestos, Crocidolite |
MAP2K1 protein inhibits the reaction [Asbestos, Crocidolite results in increased expression of IL6 mRNA] | decreases reaction|increases expression | 18192500
|
C035982 |
beryllium fluoride |
beryllium fluoride results in increased phosphorylation of MAP2K1 protein | increases phosphorylation | 11867686
|
C053541 |
bicalutamide |
bicalutamide inhibits the reaction [Dihydrotestosterone results in increased phosphorylation of and results in increased activity of MAP2K1 protein] | decreases reaction|increases activity|increases phosphorylation | 15466214
|
C053541 |
bicalutamide |
bicalutamide results in increased phosphorylation of and results in increased activity of MAP2K1 protein | increases activity|increases phosphorylation | 15466214
|
C053541 |
bicalutamide |
PD 98059 inhibits the reaction [bicalutamide results in increased phosphorylation of and results in increased activity of MAP2K1 protein] | decreases reaction|increases activity|increases phosphorylation | 15466214
|
C400082 |
bortezomib |
[bortezomib co-treated with Butyrates] results in decreased expression of MAP2K1 protein | affects cotreatment|decreases expression | 12893773
|
C400082 |
bortezomib |
[bortezomib co-treated with vorinostat] results in decreased expression of MAP2K1 protein | affects cotreatment|decreases expression | 12893773
|
D002087 |
Butyrates |
[bortezomib co-treated with Butyrates] results in decreased expression of MAP2K1 protein | affects cotreatment|decreases expression | 12893773
|
D002087 |
Butyrates |
Butyrates results in decreased expression of MAP2K1 protein | decreases expression | 12893773
|
D002087 |
Butyrates |
MAP2K1 protein mutant form results in decreased activity of [D 21266 co-treated with Butyrates] | affects cotreatment|decreases activity | 15781658
|
D000001 |
Calcimycin |
Calcimycin results in increased phosphorylation of and results in increased activity of MAP2K1 protein | increases activity|increases phosphorylation | 16000378
|
D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride affects the expression of MAP2K1 mRNA | affects expression | 17805973
|
D002392 |
Catechin |
Catechin results in decreased expression of MAP2K1 mRNA | decreases expression | 15465739
|
D002392 |
Catechin |
Catechin results in decreased expression of MAP2K1 protein | decreases expression | 15465739
|
D002392 |
Catechin |
Catechin results in increased expression of MAP2K1 mRNA | increases expression | 15465739
|
C105934 |
celecoxib |
celecoxib results in decreased phosphorylation of MAP2K1 protein | decreases phosphorylation | 16123214
|
D002713 |
Chlorine |
Chlorine results in increased expression of MAP2K1 mRNA | increases expression | 18636392
|
D002713 |
Chlorine |
[Ozone co-treated with Chlorine] results in decreased expression of MAP2K1 mRNA | affects cotreatment|decreases expression | 18636392
|
C503589 |
cis-9, trans-11-conjugated linoleic acid |
[cis-9, trans-11-conjugated linoleic acid co-treated with trans-10,cis-12-conjugated linoleic acid] results in increased phosphorylation of and results in increased activity of MAP2K1 protein | affects cotreatment|increases activity|increases phosphorylation | 17869086
|
C503589 |
cis-9, trans-11-conjugated linoleic acid |
cis-9, trans-11-conjugated linoleic acid results in increased phosphorylation of and results in increased activity of MAP2K1 protein | increases activity|increases phosphorylation | 17869086
|
C488583 |
Clostridium difficile lethal toxin B |
Clostridium difficile lethal toxin B inhibits the reaction [EDN1 protein results in increased phosphorylation of MAP2K1 protein] | decreases reaction|increases phosphorylation | 11158304
|
D003024 |
Clozapine |
Clozapine results in decreased expression of MAP2K1 mRNA | decreases expression | 15860345
|
C105905 |
D 21266 |
MAP2K1 protein mutant form results in decreased activity of [D 21266 co-treated with Butyrates] | affects cotreatment|decreases activity | 15781658
|
C105905 |
D 21266 |
MAP2K1 protein mutant form results in decreased activity of [D 21266 co-treated with trichostatin A] | affects cotreatment|decreases activity | 15781658
|
C105905 |
D 21266 |
MAP2K1 protein mutant form results in decreased activity of [D 21266 co-treated with vorinostat] | affects cotreatment|decreases activity | 15781658
|
C014347 |
decitabine |
decitabine results in increased expression of MAP2K1 mRNA | increases expression | 17785578
|
C107676 |
deguelin |
deguelin metabolite results in decreased expression of MAP2K1 protein | decreases expression | 19139008
|
C107676 |
deguelin |
deguelin results in decreased expression of MAP2K1 protein | decreases expression | 19139008 19336726
|
D004026 |
Dieldrin |
Dieldrin results in increased phosphorylation of and results in increased activity of MAP2K1 protein | increases activity|increases phosphorylation | 15888667
|
D004054 |
Diethylstilbestrol |
Diethylstilbestrol results in increased expression of MAP2K1 mRNA | increases expression | 15766595
|
D004054 |
Diethylstilbestrol |
Diethylstilbestrol results in increased expression of MAP2K1 mRNA | increases expression | 16636312
|
D004317 |
Doxorubicin |
Doxorubicin results in increased phosphorylation of MAP2K1 protein | increases phosphorylation | 17974986
|
D004317 |
Doxorubicin |
Doxorubicin results in increased phosphorylation of MAP2K1 protein | increases phosphorylation | 17974986
|
D004642 |
Emodin |
Emodin inhibits the reaction [PDGFB protein results in increased phosphorylation of MAP2K1 protein] | decreases reaction|increases phosphorylation | 15288473
|
D004726 |
Endosulfan |
Endosulfan results in increased phosphorylation of and results in increased activity of MAP2K1 protein | increases activity|increases phosphorylation | 15888667
|
C074283 |
estradiol 3-benzoate |
estradiol 3-benzoate results in decreased phosphorylation of MAP2K1 protein | decreases phosphorylation | 15778002
|
D004958 |
Estradiol |
Estradiol results in increased activity of MAP2K1 protein | increases activity | 15615701
|
D004958 |
Estradiol |
Estradiol results in increased activity of MAP2K1 protein | increases activity | 15615701
|
D004958 |
Estradiol |
Estradiol affects the expression of MAP2K1 mRNA | affects expression | 15598610
|
D004958 |
Estradiol |
Estradiol results in increased expression of MAP2K1 mRNA | increases expression | 14664709
|
D004976 |
Ethacrynic Acid |
Ethacrynic Acid results in increased expression of MAP2K1 protein | increases expression | 14556662
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol affects the expression of MAP2K1 mRNA | affects expression | 17555576
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in increased expression of MAP2K1 mRNA | increases expression | 17108234
|
D005419 |
Flavonoids |
Flavonoids results in decreased expression of MAP2K1 mRNA | decreases expression | 15465739
|
C024352 |
fludarabine |
fludarabine results in increased activity of MAP2K1 protein | increases activity | 15059916
|
C001277 |
geldanamycin |
geldanamycin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MAP2K1 protein] | decreases reaction|increases activity | 8816498
|
D019833 |
Genistein |
Genistein results in decreased phosphorylation of MAP2K1 protein | decreases phosphorylation | 15781664
|
D006152 |
Cyclic GMP |
Cyclic GMP affects the reaction [NPPA protein alternative form results in decreased phosphorylation of and results in decreased activity of MAP2K1 protein] | affects reaction|decreases activity|decreases phosphorylation | 18225537
|
D006152 |
Cyclic GMP |
Cyclic GMP results in decreased phosphorylation of MAP2K1 protein | decreases phosphorylation | 18225537
|
D006220 |
Haloperidol |
Haloperidol results in decreased expression of MAP2K1 mRNA | decreases expression | 15860345
|
D006493 |
Heparin |
Heparin inhibits the reaction [FGF1 protein results in increased phosphorylation of MAP2K1 protein] | decreases reaction|increases phosphorylation | 14966081
|
D006493 |
Heparin |
Heparin inhibits the reaction [FGF2 protein results in increased phosphorylation of MAP2K1 protein] | decreases reaction|increases phosphorylation | 14966081
|
D006533 |
Heptachlor |
Heptachlor results in decreased expression of MAP2K1 protein | decreases expression | 9704902
|
D006533 |
Heptachlor |
Heptachlor results in increased phosphorylation of and results in increased activity of MAP2K1 protein | increases activity|increases phosphorylation | 15888667
|
D006820 |
Hyaluronic Acid |
Hyaluronic Acid analog results in increased phosphorylation of MAP2K1 protein | increases phosphorylation | 12402308
|
D006861 |
Hydrogen Peroxide |
Hydrogen Peroxide results in increased activity of MAP2K1 protein | increases activity | 15242773
|
C078038 |
inchinko-to |
inchinko-to inhibits the reaction [PDGFB protein results in increased phosphorylation of MAP2K1 protein] | decreases reaction|increases phosphorylation | 15288473
|
D007213 |
Indomethacin |
Indomethacin results in increased expression of MAP2K1 mRNA | increases expression | 18299717
|
D007545 |
Isoproterenol |
MAP2K1 protein affects the reaction [Isoproterenol results in increased expression of NPPA mRNA] | affects reaction|increases expression | 10888249
|
D007545 |
Isoproterenol |
MAP2K1 protein affects the reaction [Isoproterenol results in increased phosphorylation of and results in increased activity of MAPK1 protein] | affects reaction|increases activity|increases phosphorylation | 10888249
|
D007545 |
Isoproterenol |
MAP2K1 protein affects the reaction [Isoproterenol results in increased phosphorylation of and results in increased activity of MAPK3 protein] | affects reaction|increases activity|increases phosphorylation | 10888249
|
C067431 |
letrozole |
letrozole results in increased expression of MAP2K1 protein | increases expression | 15967659
|
D001556 |
Lindane |
Lindane results in increased phosphorylation of and results in increased activity of MAP2K1 protein | increases activity|increases phosphorylation | 15888667
|
D008070 |
Lipopolysaccharides |
MAP2K1 protein promotes the reaction [Lipopolysaccharides results in increased expression of IL6 protein] | increases expression|increases reaction | 10469353
|
D008070 |
Lipopolysaccharides |
MAP2K1 protein promotes the reaction [Lipopolysaccharides results in increased expression of TNF protein] | increases expression|increases reaction | 10469353
|
C009900 |
lipoteichoic acid |
lipoteichoic acid results in increased phosphorylation of MAP2K1 protein | increases phosphorylation | 19573522
|
C009900 |
lipoteichoic acid |
Propofol inhibits the reaction [lipoteichoic acid results in increased phosphorylation of MAP2K1 protein] | decreases reaction|increases phosphorylation | 19573522
|
D008094 |
Lithium |
[Lithium results in increased phosphorylation of and results in increased activity of MAP3K8 protein] which results in increased phosphorylation of MAP2K1 protein | increases activity|increases phosphorylation | 19159680
|
C015329 |
lycopene |
lycopene results in increased expression of MAP2K1 mRNA | increases expression | 16886892
|
D008353 |
Mannitol |
Mannitol inhibits the reaction [Vitamin A results in increased phosphorylation of MAP2K1 protein] | decreases reaction|increases phosphorylation | 16510265
|
C014659 |
methyl(acetoxymethyl)nitrosamine |
methyl(acetoxymethyl)nitrosamine results in increased phosphorylation of and results in increased activity of MAP2K1 protein | increases activity|increases phosphorylation | 12693035
|
D008770 |
Methylnitrosourea |
Methylnitrosourea results in increased phosphorylation of and results in increased activity of MAP2K1 protein | increases activity|increases phosphorylation | 12693035
|
C008493 |
methylselenic acid |
methylselenic acid results in decreased expression of MAP2K1 mRNA | decreases expression | 11830524
|
C008493 |
methylselenic acid |
methylselenic acid results in increased expression of MAP2K1 mRNA | increases expression | 12517777
|
D009151 |
Mustard Gas |
Mustard Gas results in increased expression of MAP2K1 mRNA | increases expression | 18955075
|
C040015 |
myricetin |
myricetin binds to and results in decreased activity of MAP2K1 protein | affects binding|decreases activity | 17693661
|
C040015 |
myricetin |
myricetin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MAP2K1 protein] | decreases reaction|increases activity | 17693661
|
D009605 |
Nitrosomethylurethane |
Nitrosomethylurethane results in increased phosphorylation of and results in increased activity of MAP2K1 protein | increases activity|increases phosphorylation | 12693035
|
C404397 |
NSC 680410 |
NSC 680410 affects the cleavage of MAP2K1 protein | affects cleavage | 14647418
|
C404397 |
NSC 680410 |
NSC 680410 results in decreased phosphorylation of MAP2K1 protein | decreases phosphorylation | 14647418
|
C474055 |
octylphenol |
octylphenol results in increased activity of MAP2K1 protein | increases activity | 18417718
|
C474055 |
octylphenol |
U 0126 inhibits the reaction [octylphenol results in increased activity of MAP2K1 protein] | decreases reaction|increases activity | 18417718
|
C440229 |
Oleylethanolamide |
Oleylethanolamide promotes the reaction [ERBB2 protein binds to MAP2K1 protein modified form] | affects binding|increases reaction | 16269455
|
C440229 |
Oleylethanolamide |
Oleylethanolamide results in increased phosphorylation of MAP2K1 protein | increases phosphorylation | 16269455
|
C440229 |
Oleylethanolamide |
tyrphostin AG 1478 inhibits the reaction [Oleylethanolamide results in increased phosphorylation of MAP2K1 protein] | decreases reaction|increases phosphorylation | 16269455
|
D010100 |
Oxygen |
MAP2K1 protein results in increased susceptibility to Oxygen | increases response to substance | 10780954
|
D010126 |
Ozone |
[Ozone co-treated with Chlorine] results in decreased expression of MAP2K1 mRNA | affects cotreatment|decreases expression | 18636392
|
C506614 |
PD 0325901 |
PD 0325901 results in decreased activity of MAP2K1 protein | decreases activity | 19282848
|
C093973 |
PD 98059 |
PD 98059 results in decreased activity of MAP2K1 protein | decreases activity | 15817663
|
C093973 |
PD 98059 |
PD 98059 inhibits the reaction [bicalutamide results in increased phosphorylation of and results in increased activity of MAP2K1 protein] | decreases reaction|increases activity|increases phosphorylation | 15466214
|
C093973 |
PD 98059 |
PD 98059 inhibits the reaction [Dihydrotestosterone results in increased phosphorylation of and results in increased activity of MAP2K1 protein] | decreases reaction|increases activity|increases phosphorylation | 15466214
|
C093973 |
PD 98059 |
PD 98059 inhibits the reaction [EGF protein results in increased phosphorylation of MAP2K1 protein] | decreases reaction|increases phosphorylation | 15466214
|
C093973 |
PD 98059 |
PD 98059 results in decreased activity of MAP2K1 protein | decreases activity | 15313166 15179185 15955695 15184045 15242773 15896333 15666830
|
C093973 |
PD 98059 |
PD 98059 results in decreased activity of MAP2K1 protein | decreases activity | 12663507
|
C093973 |
PD 98059 |
PD 98059 results in decreased activity of MAP2K1 protein | decreases activity | 15631803
|
D010656 |
Phenylephrine |
MAP2K1 protein affects the reaction [Phenylephrine results in increased expression of NPPA mRNA] | affects reaction|increases expression | 10888249
|
D010656 |
Phenylephrine |
MAP2K1 protein affects the reaction [Phenylephrine results in increased phosphorylation of and results in increased activity of MAPK1 protein] | affects reaction|increases activity|increases phosphorylation | 10888249
|
D010656 |
Phenylephrine |
MAP2K1 protein affects the reaction [Phenylephrine results in increased phosphorylation of and results in increased activity of MAPK3 protein] | affects reaction|increases activity|increases phosphorylation | 10888249
|
D010710 |
Phosphates |
Phosphates results in increased phosphorylation of and results in increased activity of MAP2K1 protein | increases activity|increases phosphorylation | 16763222
|
D010936 |
Plant Extracts |
Plant Extracts results in decreased expression of MAP2K1 mRNA | decreases expression | 15465739
|
C025299 |
polyphenols |
polyphenols results in decreased expression of MAP2K1 mRNA | decreases expression | 15465739
|
D015742 |
Propofol |
Propofol inhibits the reaction [lipoteichoic acid results in increased phosphorylation of MAP2K1 protein] | decreases reaction|increases phosphorylation | 19573522
|
C037219 |
quinoline |
quinoline results in decreased activity of MAP2K1 protein | decreases activity | 18393446
|
C059514 |
resveratrol |
resveratrol results in increased activity of MAP2K1 protein | increases activity | 15615701
|
C059514 |
resveratrol |
resveratrol results in decreased activity of MAP2K1 protein | decreases activity | 15698585
|
C059514 |
resveratrol |
resveratrol results in decreased phosphorylation of MAP2K1 protein | decreases phosphorylation | 16761963
|
C059514 |
resveratrol |
resveratrol results in increased activity of MAP2K1 protein | increases activity | 15615701
|
C085746 |
rottlerin |
rottlerin results in decreased phosphorylation of MAP2K1 protein | decreases phosphorylation | 15949478
|
C085746 |
rottlerin |
rottlerin results in decreased phosphorylation of MAP2K1 protein | decreases phosphorylation | 15949478
|
D020123 |
Sirolimus |
Sirolimus inhibits the reaction [MAP2K1 protein results in increased activity of RPS6KB1 protein] | decreases reaction|increases activity | 12411397
|
D020123 |
Sirolimus |
Sirolimus inhibits the reaction [MAP2K1 protein results in increased phosphorylation of EIF4EBP1 protein] | decreases reaction|increases phosphorylation | 12411397
|
C017947 |
sodium arsenite |
sodium arsenite results in decreased expression of MAP2K1 mRNA | decreases expression | 12016162
|
D018038 |
Sodium Selenite |
Sodium Selenite results in decreased expression of MAP2K1 mRNA | decreases expression | 16705456
|
C025462 |
sulindac sulfide |
MAP2K1 protein inhibits the reaction [sulindac sulfide results in decreased phosphorylation of MAPK1 protein] | decreases phosphorylation|decreases reaction | 15548677
|
C025462 |
sulindac sulfide |
MAP2K1 protein inhibits the reaction [sulindac sulfide results in decreased phosphorylation of MAPK3 protein] | decreases phosphorylation|decreases reaction | 15548677
|
C025462 |
sulindac sulfide |
MAP2K1 protein inhibits the reaction [sulindac sulfide results in increased cleavage of and results in increased activity of CASP3 protein] | decreases reaction|increases activity|increases cleavage | 15548677
|
C025462 |
sulindac sulfide |
MAP2K1 protein promotes the reaction [sulindac sulfide results in increased expression of ATF3 mRNA] | increases expression|increases reaction | 16079301
|
C025463 |
sulindac sulfone |
MAP2K1 protein inhibits the reaction [sulindac sulfone results in decreased phosphorylation of MAPK1 protein] | decreases phosphorylation|decreases reaction | 15548677
|
C025463 |
sulindac sulfone |
MAP2K1 protein inhibits the reaction [sulindac sulfone results in decreased phosphorylation of MAPK3 protein] | decreases phosphorylation|decreases reaction | 15548677
|
C025463 |
sulindac sulfone |
MAP2K1 protein inhibits the reaction [sulindac sulfone results in increased cleavage of and results in increased activity of CASP3 protein] | decreases reaction|increases activity|increases cleavage | 15548677
|
D013629 |
Tamoxifen |
Tamoxifen promotes the reaction [PIN1 protein binds to MAP2K1 protein] | affects binding|increases reaction | 20479004
|
D013739 |
Testosterone |
[Testosterone results in increased activity of RAF1 protein] which results in increased activity of MAP2K1 protein | increases activity | 20372086
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased activity of MAP2K1 protein | increases activity | 15313166
|
D013749 |
Tetrachlorodibenzodioxin |
MAP2K1 protein promotes the reaction [Tetrachlorodibenzodioxin results in decreased expression of PPARG protein] | decreases expression|increases reaction | 12758056
|
D013749 |
Tetrachlorodibenzodioxin |
MAP2K1 protein promotes the reaction [Tetrachlorodibenzodioxin results in increased activity of AHR protein] | increases activity|increases reaction | 12213569
|
D013755 |
Tetradecanoylphorbol Acetate |
PIN1 protein promotes the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAP2K1 protein] | increases phosphorylation|increases reaction | 20479004
|
D013755 |
Tetradecanoylphorbol Acetate |
Tetradecanoylphorbol Acetate results in increased phosphorylation of MAP2K1 protein | increases phosphorylation | 20479004
|
D013755 |
Tetradecanoylphorbol Acetate |
geldanamycin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MAP2K1 protein] | decreases reaction|increases activity | 8816498
|
D013755 |
Tetradecanoylphorbol Acetate |
myricetin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MAP2K1 protein] | decreases reaction|increases activity | 17693661
|
D013755 |
Tetradecanoylphorbol Acetate |
Tetradecanoylphorbol Acetate results in increased activity of MAP2K1 protein | increases activity | 8816498 17693661
|
C496197 |
trans-10,cis-12-conjugated linoleic acid |
[cis-9, trans-11-conjugated linoleic acid co-treated with trans-10,cis-12-conjugated linoleic acid] results in increased phosphorylation of and results in increased activity of MAP2K1 protein | affects cotreatment|increases activity|increases phosphorylation | 17869086
|
C012589 |
trichostatin A |
MAP2K1 protein mutant form results in decreased activity of [D 21266 co-treated with trichostatin A] | affects cotreatment|decreases activity | 15781658
|
C057693 |
troglitazone |
MAP2K1 protein promotes the reaction [troglitazone results in increased expression of ATF3 mRNA] | increases expression|increases reaction | 16079301
|
C101044 |
tyrphostin AG 1478 |
tyrphostin AG 1478 inhibits the reaction [Oleylethanolamide results in increased phosphorylation of MAP2K1 protein] | decreases reaction|increases phosphorylation | 16269455
|
C113580 |
U 0126 |
U 0126 results in decreased activity of MAP2K1 protein | decreases activity | 15547725 15930308 15331595 18393446
|
C113580 |
U 0126 |
U 0126 inhibits the reaction [octylphenol results in increased activity of MAP2K1 protein] | decreases reaction|increases activity | 18417718
|
C113580 |
U 0126 |
U 0126 results in decreased activity of MAP2K1 protein | decreases activity | 18417718
|
C113580 |
U 0126 |
U 0126 inhibits the reaction [MAP2K1 protein results in increased activity of RPS6KB1 protein] | decreases reaction|increases activity | 12411397
|
C113580 |
U 0126 |
U 0126 inhibits the reaction [MAP2K1 protein results in increased phosphorylation of EIF4EBP1 protein] | decreases reaction|increases phosphorylation | 12411397
|
C113580 |
U 0126 |
U 0126 promotes the reaction [NGF protein results in increased phosphorylation of and results in increased activity of MAP2K1 protein] | increases activity|increases phosphorylation|increases reaction | 14713289
|
C113580 |
U 0126 |
U 0126 results in decreased activity of MAP2K1 protein | decreases activity | 15654950 15375559 16000378
|
D014638 |
Vanadates |
Vanadates results in increased expression of MAP2K1 protein | increases expression | 17874149
|
C459559 |
vaticanol C |
vaticanol C results in decreased expression of and results in decreased phosphorylation of MAP2K1 protein | decreases expression|decreases phosphorylation | 15725661
|
D014801 |
Vitamin A |
6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [Vitamin A results in increased phosphorylation of MAP2K1 protein] | decreases reaction|increases phosphorylation | 16510265
|
D014801 |
Vitamin A |
AG 1879 inhibits the reaction [Vitamin A results in increased phosphorylation of MAP2K1 protein] | decreases reaction|increases phosphorylation | 16510265
|
D014801 |
Vitamin A |
Mannitol inhibits the reaction [Vitamin A results in increased phosphorylation of MAP2K1 protein] | decreases reaction|increases phosphorylation | 16510265
|
D014801 |
Vitamin A |
Vitamin A results in increased phosphorylation of MAP2K1 protein | increases phosphorylation | 16510265
|
C111237 |
vorinostat |
[bortezomib co-treated with vorinostat] results in decreased expression of MAP2K1 protein | affects cotreatment|decreases expression | 12893773
|
C111237 |
vorinostat |
MAP2K1 protein mutant form results in decreased activity of [D 21266 co-treated with vorinostat] | affects cotreatment|decreases activity | 15781658
|
C111237 |
vorinostat |
vorinostat results in decreased expression of MAP2K1 protein | decreases expression | 12893773
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
3.68 | 14745880 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
2.03 | 15322242 11752688 14514962 |
MESH:D000015 |
Abnormalities, Multiple |
|
Vitamin A |
4.09 | 10992263 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
2.72 | 18287403 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
3.08 | 17505938 |
MESH:D000168 |
Acrocephalosyndactylia |
|
U 0126 |
4.65 | 17694057 |
MESH:D058186 |
Acute Kidney Injury |
|
resveratrol |
3.10 | 16538975 |
MESH:D055371 |
Acute Lung Injury |
|
Chlorine |
10.98 | 20601635 |
MESH:D055371 |
Acute Lung Injury |
|
Lipopolysaccharides |
10.98 | 18653653 11850527 |
MESH:D055371 |
Acute Lung Injury |
|
Oxygen |
10.98 | 16759491 |
MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
12.94 | 17418594 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
12.94 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
12.94 | 14692618 |
MESH:D000230 |
Adenocarcinoma |
|
Genistein |
12.94 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Indomethacin |
12.94 | 16537180 |
MESH:D000230 |
Adenocarcinoma |
|
Methylnitrosourea |
12.94 | 15688392 15113128 |
MESH:D000236 |
Adenoma |
|
Indomethacin |
5.22 | 11497255 |
MESH:D000236 |
Adenoma |
|
resveratrol |
5.22 | 15688382 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
2.54 | 16835633 |
MESH:D011125 |
Adenomatous Polyposis Coli |
|
celecoxib |
8.08 | 19003578 16215675 |
MESH:D011125 |
Adenomatous Polyposis Coli |
|
sulindac sulfone |
8.08 | 16150858 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
3.84 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
4.04 | 16712894 17306315 |
MESH:D000380 |
Agranulocytosis |
|
Clozapine |
4.22 | 16160616 12649775 14617031 |
MESH:D000382 |
Agricultural Workers' Diseases |
|
Heptachlor |
6.72 | 12661182 |
MESH:D000382 |
Agricultural Workers' Diseases |
|
Lindane |
6.72 | 12661182 |
MESH:D000419 |
Albuminuria |
|
Doxorubicin |
3.73 | 21441931 |
MESH:D016301 |
Alveolar Bone Loss |
|
Indomethacin |
4.51 | 17225004 |
MESH:D000544 |
Alzheimer Disease |
|
Indomethacin |
12.00 | 17627676 15579461 |
MESH:D000544 |
Alzheimer Disease |
|
Lithium |
12.00 | 19621015 |
MESH:D000544 |
Alzheimer Disease |
|
Ozone |
12.00 | 15513908 |
MESH:D000544 |
Alzheimer Disease |
|
Plant Extracts |
12.00 | 16962711 |
MESH:D000544 |
Alzheimer Disease |
|
resveratrol |
12.00 | 16183991 16162502 |
MESH:D000544 |
Alzheimer Disease |
|
sulindac sulfide |
12.00 | 18759972 |
MESH:D000686 |
Amyloidosis |
|
Diethylstilbestrol |
3.67 | 15469931 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
6.49 | 11748828 |
MESH:D000740 |
Anemia |
|
Vitamin A |
6.49 | 16960172 |
MESH:D018798 |
Anemia, Iron-Deficiency |
|
Vitamin A |
4.04 | 16960172 |
MESH:D000860 |
Anoxia |
|
Oxygen |
4.21 | 20872349 |
MESH:D000987 |
Antisocial Personality Disorder |
|
Testosterone |
4.99 | 7506515 |
MESH:D001014 |
Aortic Aneurysm |
|
Indomethacin |
4.04 | 10231640 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Indomethacin |
4.04 | 10388637 |
MESH:D001145 |
Arrhythmias, Cardiac |
|
Phenylephrine |
3.37 | 17460149 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
2.64 | 11256880 |
MESH:D018771 |
Arthralgia |
|
Indomethacin |
4.30 | 2160914 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
8.96 | 15885639 |
MESH:D001169 |
Arthritis, Experimental |
|
Plant Extracts |
8.96 | 14686799 |
MESH:D001169 |
Arthritis, Experimental |
|
resveratrol |
8.96 | 17115116 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Indomethacin |
3.88 | 11248219 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Ozone |
3.88 | 15570426 |
MESH:D001249 |
Asthma |
|
Mustard Gas |
5.97 | 10378619 |
MESH:D001249 |
Asthma |
|
Ozone |
5.97 | 17854713 16373670 |
MESH:D001249 |
Asthma |
|
Vitamin A |
5.97 | 16732791 |
MESH:D050197 |
Atherosclerosis |
|
Oxygen |
5.20 | 16391483 |
MESH:D050197 |
Atherosclerosis |
|
resveratrol |
5.20 | 16873680 17967414 |
MESH:D001321 |
Autistic Disorder |
|
Haloperidol |
2.83 | 19368416 18080171 |
MESH:D001321 |
Autistic Disorder |
|
Sirolimus |
2.83 | 21115397 |
MESH:D001477 |
Bartter Syndrome |
|
Indomethacin |
4.15 | 10684365 |
MESH:D001714 |
Bipolar Disorder |
|
Lithium |
3.81 | 20338123 20046352 19153942 17594078 |
MESH:D001768 |
Blister |
|
Mustard Gas |
4.31 | 19167455 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
2.28 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
2.93 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.16 | 15746008 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
3.84 | 14601052 |
MESH:D001919 |
Bradycardia |
|
Isoproterenol |
8.16 | 6740701 |
MESH:D001919 |
Bradycardia |
|
Phenylephrine |
8.16 | 15306635 |
MESH:D001929 |
Brain Edema |
|
Indomethacin |
4.16 | 11481608 |
MESH:D002545 |
Brain Ischemia |
|
Indomethacin |
12.30 | 12524144 |
MESH:D002545 |
Brain Ischemia |
|
Plant Extracts |
12.30 | 16041641 |
MESH:D002545 |
Brain Ischemia |
|
resveratrol |
12.30 | 17600658 |
MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
3.07 | 17150277 |
MESH:D001943 |
Breast Neoplasms |
|
4-(1H-imidazol-1-yl)retinoic acid |
17.58 | 17387344 17145897 |
MESH:D001943 |
Breast Neoplasms |
|
decitabine |
17.58 | 19208741 18320071 |
MESH:D001943 |
Breast Neoplasms |
|
deguelin |
17.58 | 17035597 18593368 |
MESH:D001943 |
Breast Neoplasms |
|
Dieldrin |
17.58 | 15770527 11859874 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylstilbestrol |
17.58 | 15324884 17129689 |
MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
17.58 | 16935488 18628466 15994142 18695136 11325840 19526202 17983394 15136595 16264153 15939500 18382427 16096432 16322301 15668708 17426702 18234424 15567936 16595493 16115903 15634643 15993339 16826403 17369602 15692762 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
17.58 | 12948864 19861407 17289903 17261762 14630087 18497071 16675129 17018787 |
MESH:D001943 |
Breast Neoplasms |
|
Genistein |
17.58 | 16873071 17200150 16541309 |
MESH:D001943 |
Breast Neoplasms |
|
Heptachlor |
17.58 | 8738476 |
MESH:D001943 |
Breast Neoplasms |
|
Indomethacin |
17.58 | 17401462 |
MESH:D001943 |
Breast Neoplasms |
|
letrozole |
17.58 | 17892469 16002280 |
MESH:D001943 |
Breast Neoplasms |
|
Lindane |
17.58 | 14688026 |
MESH:D001943 |
Breast Neoplasms |
|
Methylnitrosourea |
17.58 | 16253758 11306469 14633655 |
MESH:D001943 |
Breast Neoplasms |
|
Oxygen |
17.58 | 17263869 |
MESH:D001943 |
Breast Neoplasms |
|
resveratrol |
17.58 | 17651959 16393696 17534123 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
17.58 | 19221464 19155303 18997820 11161223 17049068 20135344 19410462 19011961 20390343 20005174 19289846 19142967 18815881 15668708 18821012 16202921 19244106 18351453 19059307 19084267 17440819 18629630 21138602 19115204 17261762 18984771 19200415 18855134 19487384 15565566 17242785 20544844 17893378 19189212 20859285 19189210 21152245 16873071 18425577 16818667 20065188 19103187 19288272 16273361 19066611 |
MESH:D001943 |
Breast Neoplasms |
|
Testosterone |
17.58 | 17261762 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
17.58 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
vorinostat |
17.58 | 16144943 |
MESH:D016535 |
Bronchial Hyperreactivity |
|
Ozone |
6.72 | 14754758 18417511 19059883 16777450 17626835 15516495 18315731 |
MESH:D016535 |
Bronchial Hyperreactivity |
|
tyrphostin AG 1478 |
6.72 | 12794006 |
MESH:D001989 |
Bronchiolitis Obliterans |
|
Mustard Gas |
4.31 | 15286001 |
MESH:D029481 |
Bronchitis, Chronic |
|
Mustard Gas |
4.11 | 17687719 10378619 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Vitamin A |
4.75 | 17426644 17377406 |
MESH:D002056 |
Burns |
|
Indomethacin |
3.88 | 10459503 |
MESH:D002057 |
Burns, Chemical |
|
Plant Extracts |
4.47 | 9625245 |
MESH:D002100 |
Cachexia |
|
Indomethacin |
9.59 | 11239499 15141370 16537180 15625704 |
MESH:D002100 |
Cachexia |
|
Ozone |
9.59 | 16183385 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
3.61 | 16111702 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Carbon Tetrachloride |
2.96 | 16192424 16124888 16011737 16227642 16050911 16097048 3786805 15700767 18705752 15673190 10355542 15721981 |
MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
3.95 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.11 | 16835633 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
3.67 | 19066611 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
29.05 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Carbon Tetrachloride |
29.05 | 18788625 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
deguelin |
29.05 | 18575727 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylstilbestrol |
29.05 | 16924424 15948411 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
29.05 | 17876044 18059187 16023760 16234567 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
29.05 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Genistein |
29.05 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Indomethacin |
29.05 | 16391822 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Plant Extracts |
29.05 | 18834353 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
quinoline |
29.05 | 598648 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
resveratrol |
29.05 | 19321006 16227395 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Sirolimus |
29.05 | 19335982 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
29.05 | 17306315 16507464 15276417 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
29.05 | 16924424 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
Indomethacin |
8.62 | 11053908 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
resveratrol |
8.62 | 16675471 |
MESH:D018276 |
Carcinoma, Medullary |
|
Indomethacin |
4.50 | 14736730 11352223 18791128 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
bortezomib |
7.08 | 16052434 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
sulindac sulfide |
7.08 | 12391285 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
sulindac sulfone |
7.08 | 18758305 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
celecoxib |
8.18 | 16369983 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
8.18 | 16201981 1485588 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Indomethacin |
8.18 | 17341418 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
decitabine |
16.56 | 19215824 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
16.56 | 6189445 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Indomethacin |
16.56 | 15482327 12636206 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
resveratrol |
16.56 | 16227395 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Sirolimus |
16.56 | 19435901 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
16.56 | 18572023 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tetradecanoylphorbol Acetate |
16.56 | 18922899 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
2.86 | 17572228 |
MESH:C535579 |
Cardiofaciocutaneous syndrome |
marker/mechanism |
|
| 16439621 17703371 |
MESH:D006332 |
Cardiomegaly |
|
Isoproterenol |
11.90 | 7544033 11179087 |
MESH:D006332 |
Cardiomegaly |
|
Phenylephrine |
11.90 | 16170337 11754973 17287366 15728586 11179087 17124262 |
MESH:D006332 |
Cardiomegaly |
|
Plant Extracts |
11.90 | 17645561 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
11.90 | 16120746 18670907 18850075 |
MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
6.69 | 17519947 17974986 16269455 16952015 16731534 16242529 16455267 17382496 17351982 15811867 15476868 17007740 18627295 17924179 17131338 16278810 17329180 16612575 16109756 15792986 15505089 17928571 17308081 16651473 16364871 |
MESH:D009202 |
Cardiomyopathies |
|
Oleylethanolamide |
6.69 | 16269455 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
2.57 | 16243910 17334414 |
MESH:D002318 |
Cardiovascular Diseases |
|
Genistein |
8.57 | 16332659 |
MESH:D002318 |
Cardiovascular Diseases |
|
Hydrogen Peroxide |
8.57 | 16936243 |
MESH:D002318 |
Cardiovascular Diseases |
|
resveratrol |
8.57 | 15458977 |
MESH:D002375 |
Catalepsy |
|
Haloperidol |
4.07 | 1977408 15215559 |
MESH:D002386 |
Cataract |
|
Adenosine Triphosphate |
6.40 | 15003327 |
MESH:D002386 |
Cataract |
|
Methylnitrosourea |
6.40 | 12484553 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
10.88 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
10.88 | 18566989 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Methylnitrosourea |
10.88 | 7505956 2727394 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
10.88 | 20056578 19524636 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Testosterone |
3.29 | 20678186 |
MESH:D015362 |
Child Nutrition Disorders |
|
Vitamin A |
4.61 | 16153327 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
2.43 | 16835633 |
MESH:D002764 |
Cholecystitis |
|
Indomethacin |
4.30 | 11181007 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
6.06 | 17333356 11677210 16105132 15861022 17681005 17110522 16919318 |
MESH:D002779 |
Cholestasis |
|
Vitamin A |
6.06 | 16175620 |
MESH:D019457 |
Chromosome Breakage |
|
Sodium Selenite |
3.92 | 15894690 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
4.64 | 16354765 8697196 15668235 15340226 12621046 |
MESH:D002972 |
Cleft Palate |
|
Vitamin A |
4.64 | 16054864 |
MESH:D003072 |
Cognition Disorders |
|
Clozapine |
4.14 | 17123785 |
MESH:D003092 |
Colitis |
|
resveratrol |
3.31 | 16474422 |
MESH:D003110 |
Colonic Neoplasms |
|
Butyrates |
16.01 | 15936596 |
MESH:D003110 |
Colonic Neoplasms |
|
celecoxib |
16.01 | 16004971 |
MESH:D003110 |
Colonic Neoplasms |
|
decitabine |
16.01 | 17616700 |
MESH:D003110 |
Colonic Neoplasms |
|
Genistein |
16.01 | 17182828 |
MESH:D003110 |
Colonic Neoplasms |
|
Indomethacin |
16.01 | 15637740 15963497 11260862 15786552 15936596 15625704 |
MESH:D003110 |
Colonic Neoplasms |
|
polyphenols |
16.01 | 16293270 |
MESH:D003110 |
Colonic Neoplasms |
|
resveratrol |
16.01 | 16338953 |
MESH:D003110 |
Colonic Neoplasms |
|
Vitamin A |
16.01 | 16267017 17219422 |
MESH:D015179 |
Colorectal Neoplasms |
|
celecoxib |
6.51 | 18349538 11197048 |
MESH:D015179 |
Colorectal Neoplasms |
|
decitabine |
6.51 | 18981723 |
MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
6.51 | 18802399 18259882 |
MESH:D015179 |
Colorectal Neoplasms |
|
Indomethacin |
6.51 | 18059344 12606626 17054584 11197048 |
MESH:D015179 |
Colorectal Neoplasms |
|
resveratrol |
6.51 | 16550006 |
MESH:D015179 |
Colorectal Neoplasms |
|
sulindac sulfone |
6.51 | 10416599 11197048 18059344 10666051 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.33 | 14669216 17141729 |
MESH:D003327 |
Coronary Disease |
|
resveratrol |
3.15 | 16507316 |
MESH:D018352 |
Coronavirus Infections |
|
Indomethacin |
4.85 | 17302372 |
MESH:D056685 |
Costello Syndrome |
marker/mechanism |
|
| 17703371 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.43 | 20055451 10048152 15322242 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Vitamin A |
2.43 | 10992263 |
MESH:D003456 |
Cryptorchidism |
|
Diethylstilbestrol |
3.75 | 12952375 16002989 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
8.71 | 18551238 |
MESH:D003490 |
Cyanosis |
|
Endosulfan |
8.71 | 7900959 |
MESH:D007644 |
Darier Disease |
|
Lithium |
5.06 | 20338123 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
Haloperidol |
4.05 | 20210726 |
MESH:D003704 |
Dementia |
|
Haloperidol |
3.81 | 11575062 |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
3.53 | 19031437 |
MESH:D018500 |
Diabetes Insipidus, Nephrogenic |
|
Lithium |
4.91 | 19244398 |
MESH:D003920 |
Diabetes Mellitus |
|
Sodium Selenite |
3.05 | 16285004 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
resveratrol |
3.06 | 16873680 |
MESH:D003922 |
Diabetes Mellitus, Type 1 |
|
Vitamin A |
3.17 | 16506275 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Clozapine |
7.74 | 16402076 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Genistein |
7.74 | 16647724 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
7.74 | 17107852 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
troglitazone |
7.74 | 16023994 |
MESH:D003925 |
Diabetic Angiopathies |
|
troglitazone |
4.81 | 12601628 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
15.46 | 19279558 |
MESH:D003928 |
Diabetic Nephropathies |
|
Plant Extracts |
15.46 | 19706694 |
MESH:D003928 |
Diabetic Nephropathies |
|
resveratrol |
15.46 | 16286809 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
15.46 | 19279558 |
MESH:D003967 |
Diarrhea |
|
Indomethacin |
5.93 | 7237001 7907874 |
MESH:D003967 |
Diarrhea |
|
vorinostat |
5.93 | 20479100 |
MESH:D006970 |
Disorders of Excessive Somnolence |
|
Clozapine |
4.69 | 15331141 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
13.18 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Carbon Tetrachloride |
13.18 | 19085960 15998439 4309450 19336974 15968718 6623471 2869522 3732212 16177239 7120509 17522070 11566570 21278145 16227642 10915739 7179309 9327722 6884620 7440962 3786805 10092053 15027814 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
13.18 | 17416283 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
polyphenols |
13.18 | 19370779 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Sodium Selenite |
13.18 | 15131321 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
13.18 | 20420201 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
troglitazone |
13.18 | 14986274 |
MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
5.89 | 18602426 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
5.89 | 11462148 |
MESH:D015352 |
Dry Eye Syndromes |
|
Vitamin A |
4.95 | 16146918 |
MESH:D004374 |
Ductus Arteriosus, Patent |
|
Indomethacin |
4.30 | 18043480 16326151 18446180 12774134 16133044 17190690 |
MESH:D004381 |
Duodenal Ulcer |
|
Indomethacin |
3.34 | 11595415 16699067 17329845 17202747 17151854 11595431 17045617 17351913 11535926 11991626 10671773 |
MESH:D050171 |
Dyslipidemias |
|
Clozapine |
3.53 | 16402076 |
MESH:D004417 |
Dyspnea |
|
Chlorine |
12.49 | 20016425 |
MESH:D004417 |
Dyspnea |
|
Endosulfan |
12.49 | 7900959 3388749 |
MESH:D004417 |
Dyspnea |
|
Oxygen |
12.49 | 20016425 |
MESH:C538011 |
Eales disease |
|
Vitamin A |
4.76 | 9068938 |
MESH:D004480 |
Ectromelia |
|
Vitamin A |
4.96 | 16054864 |
MESH:D004487 |
Edema |
|
Indomethacin |
17.30 | 7990266 16100529 8985016 7907874 10653021 19703484 8273558 |
MESH:D004487 |
Edema |
|
Mustard Gas |
17.30 | 11428631 9260866 11402378 11428647 |
MESH:D004487 |
Edema |
|
Plant Extracts |
17.30 | 12787963 |
MESH:D004487 |
Edema |
|
resveratrol |
17.30 | 8985016 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
17.30 | 12711302 11000095 |
MESH:D004487 |
Edema |
|
Tetradecanoylphorbol Acetate |
17.30 | 15177302 7812673 11698051 8273558 16716910 9599246 8113982 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.04 | 15322242 18230668 16714409 |
MESH:D004646 |
Emphysema |
|
Endosulfan |
5.69 | 7900959 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
10.71 | 12538720 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
resveratrol |
10.71 | 17872969 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
10.71 | 19031437 |
MESH:D004701 |
Endocrine Gland Neoplasms |
|
decitabine |
11.16 | 19294695 |
MESH:D004701 |
Endocrine Gland Neoplasms |
|
trichostatin A |
11.16 | 19294695 |
MESH:D004714 |
Endometrial Hyperplasia |
|
Diethylstilbestrol |
9.08 | 16402032 |
MESH:D004714 |
Endometrial Hyperplasia |
|
Genistein |
9.08 | 16402032 |
MESH:D016889 |
Endometrial Neoplasms |
|
Diethylstilbestrol |
16.87 | 15700306 16804899 |
MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
16.87 | 17359293 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
16.87 | 19148513 11473722 18566989 |
MESH:D016889 |
Endometrial Neoplasms |
|
Genistein |
16.87 | 11473722 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
16.87 | 19155303 17893378 16202921 20544844 |
MESH:D004715 |
Endometriosis |
|
celecoxib |
11.13 | 15652904 |
MESH:D004715 |
Endometriosis |
|
Indomethacin |
11.13 | 15652904 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
11.13 | 10568697 9294722 |
MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
11.19 | 18037988 |
MESH:D004719 |
Endomyocardial Fibrosis |
|
Plant Extracts |
11.19 | 15268973 |
MESH:D019446 |
Endotoxemia |
|
Indomethacin |
7.85 | 18509659 |
MESH:D019446 |
Endotoxemia |
|
Lipopolysaccharides |
7.85 | 15821434 15328337 17637181 |
MESH:D004751 |
Enteritis |
|
Indomethacin |
3.89 | 16328016 10567023 17763956 |
MESH:D020345 |
Enterocolitis, Necrotizing |
|
Indomethacin |
9.62 | 17980183 |
MESH:D020345 |
Enterocolitis, Necrotizing |
|
resveratrol |
9.62 | 17923197 |
MESH:D004802 |
Eosinophilia |
|
Indomethacin |
3.24 | 11298111 |
MESH:D004827 |
Epilepsy |
|
Plant Extracts |
3.22 | 19700373 19439326 |
MESH:D004890 |
Erythema |
|
Mustard Gas |
4.31 | 9357497 |
MESH:D004938 |
Esophageal Neoplasms |
|
Indomethacin |
2.54 | 11005569 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
2.34 | 11564622 |
MESH:D005221 |
Fatigue |
|
vorinostat |
4.75 | 20479100 |
MESH:D005234 |
Fatty Liver |
|
Carbon Tetrachloride |
12.57 | 15959796 17595544 16045604 61145 12631006 16239168 12795759 19224547 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
12.57 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
Plant Extracts |
12.57 | 15975614 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
12.57 | 19224547 14986274 |
MESH:D052776 |
Female Urogenital Diseases |
|
Diethylstilbestrol |
6.26 | 16002989 16513791 16534752 16611131 15751030 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
6.26 | 16709447 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
2.63 | 11858732 |
MESH:D005327 |
Fetal Resorption |
|
Vitamin A |
4.50 | 16054864 |
MESH:D005334 |
Fever |
|
Indomethacin |
6.86 | 17627676 10431976 11852909 |
MESH:D005334 |
Fever |
|
Lipopolysaccharides |
6.86 | 9205823 11852909 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
3.68 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
8.63 | 19069698 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
8.63 | 19069698 |
MESH:D005354 |
Fibrosarcoma |
|
Indomethacin |
9.39 | 10962813 |
MESH:D005354 |
Fibrosarcoma |
|
Methylnitrosourea |
9.39 | 11555667 |
MESH:D005355 |
Fibrosis |
|
Carbon Tetrachloride |
14.53 | 18705752 |
MESH:D005355 |
Fibrosis |
|
Emodin |
14.53 | 19474275 |
MESH:D005355 |
Fibrosis |
|
Indomethacin |
14.53 | 17994277 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
14.53 | 20067830 |
MESH:D005391 |
Firesetting Behavior |
|
Testosterone |
4.99 | 7506515 |
MESH:D005499 |
Folliculitis |
|
Indomethacin |
4.30 | 11298111 |
MESH:D005739 |
Gas Poisoning |
|
Chlorine |
9.17 | 20016425 |
MESH:D005739 |
Gas Poisoning |
|
Oxygen |
9.17 | 20016425 |
MESH:D005756 |
Gastritis |
|
Indomethacin |
3.89 | 15046732 |
MESH:D005833 |
Genital Neoplasms, Female |
|
Diethylstilbestrol |
10.00 | 16452187 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
10.00 | 16452187 |
MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
19.89 | 17150277 |
MESH:D005909 |
Glioblastoma |
|
Genistein |
19.89 | 16598420 |
MESH:D005909 |
Glioblastoma |
|
Indomethacin |
19.89 | 12870263 |
MESH:D005909 |
Glioblastoma |
|
myricetin |
19.89 | 19804834 |
MESH:D005909 |
Glioblastoma |
|
Testosterone |
19.89 | 17162496 |
MESH:D005909 |
Glioblastoma |
|
trichostatin A |
19.89 | 18801729 |
MESH:D005910 |
Glioma |
|
Indomethacin |
5.06 | 16487511 18371953 |
MESH:D005910 |
Glioma |
|
Methylnitrosourea |
5.06 | 9825942 |
MESH:D005923 |
Glomerulosclerosis, Focal Segmental |
|
Indomethacin |
3.58 | 11849393 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
3.73 | 10696789 |
MESH:D006073 |
Gout |
|
Indomethacin |
4.50 | 11248219 |
MESH:D006258 |
Head and Neck Neoplasms |
|
decitabine |
13.40 | 19215824 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
13.40 | 15692506 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Indomethacin |
13.40 | 15482327 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Sirolimus |
13.40 | 19435901 |
MESH:D006330 |
Heart Defects, Congenital |
|
Lithium |
8.35 | 19638421 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
8.35 | 10048152 11294989 |
MESH:D006330 |
Heart Defects, Congenital |
|
Vitamin A |
8.35 | 16080930 10992263 |
MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
2.86 | 16144979 18006777 16244372 17875725 18674790 16879835 12587719 14766674 16707910 16495754 16244371 16330681 17888722 |
MESH:D006333 |
Heart Failure |
|
Doxorubicin |
8.72 | 17481944 |
MESH:D006333 |
Heart Failure |
|
Isoproterenol |
8.72 | 18097624 |
MESH:D006333 |
Heart Failure |
|
Plant Extracts |
8.72 | 18097624 |
MESH:D006390 |
Hemangioendothelioma |
|
quinoline |
5.04 | 598648 |
MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
7.08 | 15692506 |
MESH:D006394 |
Hemangiosarcoma |
|
quinoline |
7.08 | 598648 |
MESH:D006463 |
Hemolytic-Uremic Syndrome |
|
Lipopolysaccharides |
3.63 | 16366002 |
MESH:D006470 |
Hemorrhage |
|
Endosulfan |
7.88 | 7900959 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
7.88 | 11000095 |
MESH:D006501 |
Hepatic Encephalopathy |
|
Indomethacin |
3.80 | 15633222 |
MESH:D006505 |
Hepatitis |
|
Carbon Tetrachloride |
2.80 | 19110552 19900420 |
MESH:D019698 |
Hepatitis C, Chronic |
|
Indomethacin |
3.87 | 15135802 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
2.09 | 15340226 16120746 12621046 |
MESH:D006548 |
Hernia, Diaphragmatic |
|
Vitamin A |
3.24 | 16490937 16877224 17436238 15707848 16292552 16863852 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
4.17 | 15709030 |
MESH:D006561 |
Herpes Simplex |
|
Plant Extracts |
7.33 | 10715843 |
MESH:D006561 |
Herpes Simplex |
|
resveratrol |
7.33 | 16876885 |
MESH:D006628 |
Hirsutism |
|
Testosterone |
4.79 | 17019078 |
MESH:D015658 |
HIV Infections |
|
Plant Extracts |
5.40 | 12878215 |
MESH:D015658 |
HIV Infections |
|
Vitamin A |
5.40 | 16960176 |
MESH:D006679 |
HIV Seropositivity |
|
Vitamin A |
4.75 | 17209195 |
MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
5.09 | 18501091 17606976 15147373 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
5.09 | 12676792 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
7.49 | 17088409 |
MESH:D019584 |
Hot Flashes |
|
Plant Extracts |
7.49 | 14716179 16566672 17454163 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.18 | 18606429 8697196 16354765 15340226 16959395 |
MESH:D006930 |
Hyperalgesia |
|
Indomethacin |
3.09 | 12727271 |
MESH:D034321 |
Hyperamylasemia |
|
Indomethacin |
4.85 | 17883296 |
MESH:D017588 |
Hyperandrogenism |
|
Testosterone |
4.45 | 17019078 |
MESH:D006932 |
Hyperbilirubinemia |
|
Carbon Tetrachloride |
3.68 | 16899240 |
MESH:D006934 |
Hypercalcemia |
|
bortezomib |
4.68 | 18089816 |
MESH:D006937 |
Hypercholesterolemia |
|
resveratrol |
3.24 | 17188708 |
MESH:D006940 |
Hyperemia |
|
Indomethacin |
4.16 | 12524144 |
MESH:D020138 |
Hyperhomocysteinemia |
|
Catechin |
7.48 | 17292331 |
MESH:D020138 |
Hyperhomocysteinemia |
|
Plant Extracts |
7.48 | 16484555 |
MESH:D006948 |
Hyperkinesis |
|
Clozapine |
4.06 | 16046005 |
MESH:D006949 |
Hyperlipidemias |
|
Indomethacin |
11.09 | 17546600 |
MESH:D006949 |
Hyperlipidemias |
|
Plant Extracts |
11.09 | 15268973 15975614 |
MESH:D006949 |
Hyperlipidemias |
|
resveratrol |
11.09 | 16873680 |
MESH:D006965 |
Hyperplasia |
|
Diethylstilbestrol |
3.61 | 14722030 12960047 |
MESH:D006973 |
Hypertension |
|
Phenylephrine |
3.92 | 8949925 12717712 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
3.92 | 18670907 18850075 |
MESH:D006975 |
Hypertension, Portal |
|
Carbon Tetrachloride |
3.26 | 15338365 |
MESH:D006984 |
Hypertrophy |
|
Isoproterenol |
13.49 | 12791704 |
MESH:D006984 |
Hypertrophy |
|
Phenylephrine |
13.49 | 18502941 12791704 |
MESH:D006984 |
Hypertrophy |
|
Sirolimus |
13.49 | 19211884 |
MESH:D017379 |
Hypertrophy, Left Ventricular |
|
resveratrol |
3.55 | 17488730 |
MESH:D006986 |
Hypervitaminosis A |
|
Vitamin A |
5.30 | 16054864 |
MESH:D007006 |
Hypogonadism |
|
Testosterone |
3.94 | 12002444 |
MESH:D007018 |
Hypopituitarism |
|
Testosterone |
5.34 | 17426086 |
MESH:D007021 |
Hypospadias |
|
Diethylstilbestrol |
8.49 | 16002989 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
8.49 | 16945680 16569931 |
MESH:D007022 |
Hypotension |
|
Isoproterenol |
4.02 | 6740701 |
MESH:D007077 |
Ileal Diseases |
|
Indomethacin |
4.16 | 18306037 10574470 |
MESH:D007079 |
Ileitis |
|
Indomethacin |
4.50 | 10651667 16133968 10647630 |
MESH:D007174 |
Impulse Control Disorders |
|
Testosterone |
4.99 | 7506515 |
MESH:D007235 |
Infant, Premature, Diseases |
|
Indomethacin |
4.51 | 16133044 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
resveratrol |
3.82 | 17600658 |
MESH:D007246 |
Infertility |
|
Diethylstilbestrol |
3.55 | 15036965 |
MESH:D007247 |
Infertility, Female |
|
Dieldrin |
7.67 | 10630421 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
7.67 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
decitabine |
14.59 | 17581917 |
MESH:D007248 |
Infertility, Male |
|
Endosulfan |
14.59 | 9432128 8588293 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
14.59 | 17937319 |
MESH:D007248 |
Infertility, Male |
|
Methylnitrosourea |
14.59 | 7193160 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
14.59 | 12646999 15346721 |
MESH:D007249 |
Inflammation |
|
Flavonoids |
26.21 | 17296493 |
MESH:D007249 |
Inflammation |
|
Indomethacin |
26.21 | 3291741 12568917 7812673 |
MESH:D007249 |
Inflammation |
|
Lipopolysaccharides |
26.21 | 17237260 9205823 12878042 17255318 17963957 |
MESH:D007249 |
Inflammation |
|
Mustard Gas |
26.21 | 11428620 11428631 9260866 11402378 8975870 16001271 17524151 9357497 11428647 |
MESH:D007249 |
Inflammation |
|
Plant Extracts |
26.21 | 12787963 15997105 19332304 16366677 |
MESH:D007249 |
Inflammation |
|
polyphenols |
26.21 | 16366677 |
MESH:D007249 |
Inflammation |
|
resveratrol |
26.21 | 16366677 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
26.21 | 19457130 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
26.21 | 12878042 12200463 |
MESH:D007249 |
Inflammation |
|
Tetradecanoylphorbol Acetate |
26.21 | 7812673 15177302 8273558 7562506 11698051 |
MESH:D007251 |
Influenza, Human |
|
resveratrol |
3.69 | 16624496 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
5.39 | 16627594 16393666 |
MESH:D007333 |
Insulin Resistance |
|
Sodium Selenite |
5.39 | 14714311 |
MESH:D007410 |
Intestinal Diseases |
|
Indomethacin |
3.51 | 18236018 17329856 15610444 11713966 11855677 15831440 17994277 10210152 11686837 |
MESH:D007414 |
Intestinal Neoplasms |
|
Plant Extracts |
3.87 | 12351151 12584176 12628509 |
MESH:D019586 |
Intracranial Hypertension |
|
Indomethacin |
11.32 | 15241188 |
MESH:D019586 |
Intracranial Hypertension |
|
Vitamin A |
11.32 | 15955940 |
MESH:D019189 |
Iron Metabolism Disorders |
|
Lipopolysaccharides |
3.84 | 17255318 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
2.56 | 16580747 |
MESH:D007579 |
Jejunal Diseases |
|
Indomethacin |
4.16 | 16133968 10574470 18306037 |
MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
9.89 | 16775033 15369732 15699352 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
9.89 | 15618244 |
MESH:D007674 |
Kidney Diseases |
|
Indomethacin |
9.89 | 17190690 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
9.89 | 20008137 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
7.56 | 16707910 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Hydrogen Peroxide |
7.56 | 16518626 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
11.97 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
Diethylstilbestrol |
11.97 | 14681315 15003126 16762066 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
11.97 | 15610895 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
11.97 | 18625569 |
MESH:D007859 |
Learning Disorders |
|
Diethylstilbestrol |
7.38 | 17184923 |
MESH:D007859 |
Learning Disorders |
|
Endosulfan |
7.38 | 8157075 |
MESH:D016773 |
Leishmaniasis, Cutaneous |
|
Indomethacin |
3.20 | 12228301 11703811 10320625 |
MESH:D007938 |
Leukemia |
|
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one |
7.70 | 12970779 |
MESH:D007938 |
Leukemia |
|
decitabine |
7.70 | 19235587 18980019 |
MESH:D007938 |
Leukemia |
|
Genistein |
7.70 | 18980019 17468513 |
MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
11.36 | 16085563 |
MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
troglitazone |
11.36 | 16085563 |
MESH:D015451 |
Leukemia, Lymphocytic, Chronic, B-Cell |
|
fludarabine |
4.13 | 18172266 17802794 18587576 17296974 17658394 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
bortezomib |
8.01 | 18089816 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
Emodin |
8.01 | 17077332 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
PD 98059 |
9.28 | 16972261 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
U 0126 |
9.28 | 16972261 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
Indomethacin |
3.26 | 15631656 10785260 16572323 |
MESH:D007951 |
Leukemia, Myeloid |
|
decitabine |
3.23 | 19117987 17236224 18454857 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide |
9.05 | 16467208 17077328 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
bortezomib |
9.05 | 20471514 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
decitabine |
9.05 | 19010910 18206229 18460780 18704418 17679729 19387464 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Indomethacin |
9.05 | 18360721 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
trichostatin A |
9.05 | 18206229 |
MESH:D015477 |
Leukemia, Myelomonocytic, Chronic |
|
decitabine |
4.60 | 18055864 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide |
6.47 | 17077328 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
resveratrol |
6.47 | 16087638 |
MESH:D007964 |
Leukocytosis |
|
Indomethacin |
4.51 | 16537180 |
MESH:D007969 |
Leukomalacia, Periventricular |
|
Indomethacin |
4.85 | 17980183 |
MESH:D007970 |
Leukopenia |
|
Lipopolysaccharides |
3.85 | 15821434 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Methylnitrosourea |
6.65 | 15526292 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Vitamin A |
6.65 | 16054864 |
MESH:D008064 |
Lipidoses |
|
Clozapine |
5.91 | 17567588 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
5.91 | 17567588 15342952 |
MESH:D008101 |
Liver Abscess, Amebic |
|
Indomethacin |
4.85 | 11479899 |
MESH:D008103 |
Liver Cirrhosis |
|
Carbon Tetrachloride |
8.10 | 21278145 16943688 17334410 11903743 16239168 16221502 17157831 17174718 11408273 |
MESH:D008103 |
Liver Cirrhosis |
|
Plant Extracts |
8.10 | 17157831 |
MESH:D008103 |
Liver Cirrhosis |
|
Vitamin A |
8.10 | 16256175 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Carbon Tetrachloride |
26.13 | 17481882 10355542 15818738 17823541 12389079 16011737 12632514 15057751 14620537 12958196 15931870 15650968 18472094 18187930 18376398 14716496 17922224 15893842 14748882 16033810 12445418 13678700 17714472 16097048 18054572 18205269 18251166 17900296 12546737 18317297 18412020 17766677 17869086 18279442 15925388 20821823 15338365 15052691 12898905 16116963 15730626 18156304 17805973 18705752 16638106 11481614 18472332 14512876 17698563 14716833 12649538 18263696 12586293 15876570 18210741 15959796 15996030 17944888 15673190 18166357 16136751 17640975 18277467 12445421 16248980 15370692 17557913 18481824 17708605 17525996 18006644 17721639 12741479 12667390 16015684 18418968 17761835 18420326 18395914 16192424 15123356 17565644 15362042 12632512 18429990 17631135 16027843 12609069 18339082 18395095 12666154 14724832 17976157 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
cis-9, trans-11-conjugated linoleic acid |
26.13 | 17869086 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
26.13 | 16595196 16439617 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Emodin |
26.13 | 15288473 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
26.13 | 14716833 14659978 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Genistein |
26.13 | 17823541 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Heparin |
26.13 | 16904936 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
inchinko-to |
26.13 | 15288473 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Indomethacin |
26.13 | 18194892 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Lipopolysaccharides |
26.13 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Plant Extracts |
26.13 | 15479170 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Sirolimus |
26.13 | 17050028 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
26.13 | 18564211 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
26.13 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Vitamin A |
26.13 | 16248980 |
MESH:D008107 |
Liver Diseases |
|
Carbon Tetrachloride |
9.12 | 15830285 15720792 17285989 16964402 16246199 |
MESH:D008107 |
Liver Diseases |
|
Lindane |
9.12 | 1715830 |
MESH:D008107 |
Liver Diseases |
|
Plant Extracts |
9.12 | 17034775 |
MESH:D008107 |
Liver Diseases |
|
polyphenols |
9.12 | 16698588 |
MESH:D008107 |
Liver Diseases |
|
Vitamin A |
9.12 | 16175620 |
MESH:D008108 |
Liver Diseases, Alcoholic |
|
Vitamin A |
4.33 | 16762690 |
MESH:D017093 |
Liver Failure |
|
Carbon Tetrachloride |
3.33 | 15123358 |
MESH:D017114 |
Liver Failure, Acute |
|
Carbon Tetrachloride |
2.94 | 16899240 14706259 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
25.01 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
Carbon Tetrachloride |
25.01 | 19294768 |
MESH:D008113 |
Liver Neoplasms |
|
Dieldrin |
25.01 | 8742319 9539021 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylstilbestrol |
25.01 | 16712894 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
Heptachlor |
25.01 | 2422723 9544696 |
MESH:D008113 |
Liver Neoplasms |
|
Plant Extracts |
25.01 | 19168119 |
MESH:D008113 |
Liver Neoplasms |
|
resveratrol |
25.01 | 19812893 19073162 20405173 19321006 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
25.01 | 15276417 16712894 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
25.01 | 16684651 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
25.01 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
12.41 | 2876784 6135515 2876786 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Carbon Tetrachloride |
12.41 | 12014681 15583823 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
12.41 | 17085340 16842330 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
12.41 | 12151625 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Vitamin A |
12.41 | 17113696 |
MESH:D038061 |
Lower Extremity Deformities, Congenital |
|
Methylnitrosourea |
4.63 | 16080182 |
MESH:D008171 |
Lung Diseases |
|
Mustard Gas |
12.52 | 18161513 18702808 |
MESH:D008171 |
Lung Diseases |
|
Ozone |
12.52 | 8266340 19066396 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
12.52 | 19095001 |
MESH:D008171 |
Lung Diseases |
|
Vitamin A |
12.52 | 16863852 |
MESH:D055370 |
Lung Injury |
|
Asbestos, Crocidolite |
14.92 | 17365036 |
MESH:D055370 |
Lung Injury |
|
Lipopolysaccharides |
14.92 | 21114838 |
MESH:D055370 |
Lung Injury |
|
Oxygen |
14.92 | 18339021 |
MESH:D055370 |
Lung Injury |
|
Ozone |
14.92 | 20417186 |
MESH:D008175 |
Lung Neoplasms |
|
deguelin |
16.04 | 16288123 19336726 |
MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
16.04 | 17418594 6189445 |
MESH:D008175 |
Lung Neoplasms |
|
Indomethacin |
16.04 | 11053908 11497255 16537180 |
MESH:D008175 |
Lung Neoplasms |
|
Methylnitrosourea |
16.04 | 18062963 |
MESH:D008175 |
Lung Neoplasms |
|
Mustard Gas |
16.04 | 8781369 3148597 |
MESH:D008175 |
Lung Neoplasms |
|
Ozone |
16.04 | 8597069 7614698 |
MESH:D008175 |
Lung Neoplasms |
|
Plant Extracts |
16.04 | 20869020 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
16.04 | 16712894 15276417 17306315 17077188 19931552 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
16.04 | 18625569 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
16.04 | 11884234 19555203 |
MESH:D008175 |
Lung Neoplasms |
|
Tetradecanoylphorbol Acetate |
16.04 | 11807781 |
MESH:D008181 |
Lupus Nephritis |
|
Diethylstilbestrol |
4.30 | 15166399 |
MESH:D008223 |
Lymphoma |
|
bortezomib |
16.61 | 16098063 |
MESH:D008223 |
Lymphoma |
|
decitabine |
16.61 | 19470736 |
MESH:D008223 |
Lymphoma |
|
Diethylstilbestrol |
16.61 | 15700306 |
MESH:D008223 |
Lymphoma |
|
Doxorubicin |
16.61 | 16098063 |
MESH:D008223 |
Lymphoma |
|
Methylnitrosourea |
16.61 | 11418001 16257854 |
MESH:D016393 |
Lymphoma, B-Cell |
|
bortezomib |
18.05 | 16675587 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Methylnitrosourea |
18.05 | 14633661 |
MESH:D016393 |
Lymphoma, B-Cell |
|
resveratrol |
18.05 | 17088997 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Sodium Selenite |
18.05 | 14737004 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
6.50 | 17654614 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
resveratrol |
6.50 | 14749477 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
3.74 | 15621674 |
MESH:D016410 |
Lymphoma, T-Cell, Cutaneous |
|
vorinostat |
4.85 | 20479100 |
MESH:D052801 |
Male Urogenital Diseases |
|
Diethylstilbestrol |
4.65 | 16002989 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
resveratrol |
7.21 | 15688416 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
7.21 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
celecoxib |
26.78 | 12104042 19196722 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
26.78 | 15458769 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
26.78 | 11807958 11408345 17203775 16891317 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
estradiol 3-benzoate |
26.78 | 15375486 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Genistein |
26.78 | 14578162 12929590 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Methylnitrosourea |
26.78 | 10767621 19196723 11807958 16944150 15113128 11751437 16619500 10838139 15313902 16051031 14999141 16827153 17131329 15688392 12931682 17020996 14633655 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
resveratrol |
26.78 | 11606380 8985016 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
26.78 | 16827153 19196722 11731420 14580682 19196723 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tetradecanoylphorbol Acetate |
26.78 | 8985016 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
9.78 | 19453300 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
9.78 | 19453300 |
MESH:D008527 |
Medulloblastoma |
|
bortezomib |
3.81 | 19213072 |
MESH:D008545 |
Melanoma |
|
6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid |
16.66 | 17992120 |
MESH:D008545 |
Melanoma |
|
decitabine |
16.66 | 16505122 17785578 |
MESH:D008545 |
Melanoma |
|
Doxorubicin |
16.66 | 16827129 |
MESH:D008545 |
Melanoma |
|
PD 0325901 |
16.66 | 19282848 |
MESH:D008545 |
Melanoma |
|
resveratrol |
16.66 | 17992120 |
MESH:D008545 |
Melanoma |
|
Sirolimus |
16.66 | 19282848 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
16.66 | 16487513 19082730 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
16.66 | 12393984 19393235 |
MESH:D008545 |
Melanoma |
|
trichostatin A |
16.66 | 16505122 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
3.34 | 15990972 |
MESH:D001523 |
Mental Disorders |
|
Clozapine |
8.70 | 16856516 |
MESH:D001523 |
Mental Disorders |
|
Haloperidol |
8.70 | 16856516 |
MESH:D001523 |
Mental Disorders |
|
Phosphates |
8.70 | 12686366 |
MESH:D008654 |
Mesothelioma |
|
Asbestos, Crocidolite |
4.98 | 18303189 16966607 16166281 |
MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
4.98 | 17638057 |
MESH:D008659 |
Metabolic Diseases |
|
resveratrol |
3.60 | 17112576 |
MESH:D024821 |
Metabolic Syndrome X |
|
Clozapine |
3.69 | 19142101 |
MESH:D008679 |
Metaplasia |
|
Ozone |
4.24 | 10496685 |
MESH:D008881 |
Migraine Disorders |
|
Indomethacin |
3.04 | 11903285 |
MESH:D020326 |
Migraine without Aura |
|
Cyclic GMP |
5.19 | 11304026 |
MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
3.72 | 15792986 |
MESH:D009062 |
Mouth Neoplasms |
|
Indomethacin |
6.94 | 12636206 |
MESH:D009062 |
Mouth Neoplasms |
|
Sirolimus |
6.94 | 19435901 |
MESH:D052016 |
Mucositis |
|
Doxorubicin |
3.94 | 17415656 |
MESH:D009101 |
Multiple Myeloma |
|
2,5-dimethylcelecoxib |
24.17 | 16123214 |
MESH:D009101 |
Multiple Myeloma |
|
bortezomib |
24.17 | 19112201 19372569 19112817 |
MESH:D009101 |
Multiple Myeloma |
|
celecoxib |
24.17 | 16123214 |
MESH:D009101 |
Multiple Myeloma |
|
decitabine |
24.17 | 18172295 |
MESH:D009101 |
Multiple Myeloma |
|
resveratrol |
24.17 | 16267019 16490592 17164350 17049120 14749477 17935668 |
MESH:D009101 |
Multiple Myeloma |
|
trichostatin A |
24.17 | 18172295 |
MESH:D009101 |
Multiple Myeloma |
|
Vitamin A |
24.17 | 16374440 |
MESH:D009134 |
Muscular Atrophy, Spinal |
|
resveratrol |
4.02 | 17962980 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
decitabine |
2.83 | 18608210 19157545 16882708 19010910 |
MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
13.15 | 19429709 15857846 |
MESH:D009203 |
Myocardial Infarction |
|
Genistein |
13.15 | 17141266 |
MESH:D009203 |
Myocardial Infarction |
|
Isoproterenol |
13.15 | 15740881 16538859 19172585 19595682 16584858 16697266 17052832 |
MESH:D009203 |
Myocardial Infarction |
|
Lithium |
13.15 | 16288908 |
MESH:D009203 |
Myocardial Infarction |
|
resveratrol |
13.15 | 16525036 17015251 17188708 16317513 17125593 16456233 |
MESH:D017202 |
Myocardial Ischemia |
|
resveratrol |
6.67 | 17015251 17125593 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
6.67 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
6.23 | 16810080 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Genistein |
6.23 | 17141266 |
MESH:D009205 |
Myocarditis |
|
resveratrol |
3.91 | 17322642 |
MESH:D009325 |
Nausea |
|
vorinostat |
4.66 | 20479100 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
3.02 | 18551238 7678174 |
MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
10.06 | 18259882 |
MESH:D009362 |
Neoplasm Metastasis |
|
Indomethacin |
10.06 | 11053908 11239499 16537180 |
MESH:D009362 |
Neoplasm Metastasis |
|
quinoline |
10.06 | 598648 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
10.06 | 19393235 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.16 | 19410462 |
MESH:D009369 |
Neoplasms |
|
decitabine |
19.50 | 19470736 19116145 17925555 |
MESH:D009369 |
Neoplasms |
|
deguelin |
19.50 | 17764071 |
MESH:D009369 |
Neoplasms |
|
Dieldrin |
19.50 | 8820588 |
MESH:D009369 |
Neoplasms |
|
Diethylstilbestrol |
19.50 | 15313581 |
MESH:D009369 |
Neoplasms |
|
Lindane |
19.50 | 12807735 16818664 |
MESH:D009369 |
Neoplasms |
|
lycopene |
19.50 | 17051425 |
MESH:D009369 |
Neoplasms |
|
Methylnitrosourea |
19.50 | 15533788 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
19.50 | 11559025 |
MESH:D009374 |
Neoplasms, Experimental |
|
Indomethacin |
15.09 | 15625704 10663608 |
MESH:D009374 |
Neoplasms, Experimental |
|
Methylnitrosourea |
15.09 | 12696579 |
MESH:D009374 |
Neoplasms, Experimental |
|
resveratrol |
15.09 | 8985016 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
15.09 | 20056578 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
celecoxib |
8.32 | 19196722 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
8.32 | 19189210 19196722 19200415 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
2.89 | 17289903 |
MESH:D009401 |
Nephrosis |
|
Doxorubicin |
3.94 | 16636307 16899518 |
MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
3.27 | 16889571 15640375 |
MESH:D009421 |
Nervous System Malformations |
|
Diethylstilbestrol |
16.87 | 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
16.87 | 16427766 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Genistein |
16.87 | 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
16.87 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
5.65 | 12854658 |
MESH:D009436 |
Neural Tube Defects |
|
Vitamin A |
5.65 | 17400914 |
MESH:D009442 |
Neurilemmoma |
|
Methylnitrosourea |
4.64 | 11555667 |
MESH:D019954 |
Neurobehavioral Manifestations |
|
Plant Extracts |
4.35 | 17168769 |
MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
2.75 | 15555623 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Indomethacin |
6.37 | 12349958 |
MESH:D019636 |
Neurodegenerative Diseases |
|
resveratrol |
6.37 | 17652729 |
MESH:D020078 |
Neurogenic Inflammation |
|
resveratrol |
3.61 | 17929310 |
MESH:D009503 |
Neutropenia |
|
Mustard Gas |
3.19 | 16761898 7688884 |
MESH:D009634 |
Noonan Syndrome |
marker/mechanism |
|
| 17703371 |
MESH:D009765 |
Obesity |
|
Clozapine |
4.17 | 18515891 19142110 |
MESH:D009765 |
Obesity |
|
Plant Extracts |
4.17 | 19056576 20132043 |
MESH:D007752 |
Obstetric Labor, Premature |
|
Indomethacin |
4.30 | 6374098 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
2.69 | 16049721 |
MESH:D010003 |
Osteoarthritis |
|
Indomethacin |
3.09 | 7009135 |
MESH:D010024 |
Osteoporosis |
|
anthranilic acid |
6.17 | 17042918 |
MESH:D010024 |
Osteoporosis |
|
Genistein |
6.17 | 19401787 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Genistein |
7.53 | 16169203 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
resveratrol |
7.53 | 17513867 |
MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
3.41 | 15930896 |
MESH:D010051 |
Ovarian Neoplasms |
|
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one |
17.22 | 16211241 |
MESH:D010051 |
Ovarian Neoplasms |
|
decitabine |
17.22 | 19331143 19259094 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
17.22 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
Genistein |
17.22 | 19005980 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
17.22 | 17306315 15276417 |
MESH:D010051 |
Ovarian Neoplasms |
|
trichostatin A |
17.22 | 19331143 |
MESH:D010051 |
Ovarian Neoplasms |
|
U 0126 |
17.22 | 16211241 |
MESH:D010146 |
Pain |
|
Indomethacin |
2.80 | 17440234 13679232 17627676 3291741 |
MESH:D010149 |
Pain, Postoperative |
|
Indomethacin |
3.82 | 18702446 12538197 |
MESH:D010190 |
Pancreatic Neoplasms |
|
decitabine |
9.09 | 19294695 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Methylnitrosourea |
9.09 | 16965848 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tetradecanoylphorbol Acetate |
9.09 | 15976015 |
MESH:D010190 |
Pancreatic Neoplasms |
|
trichostatin A |
9.09 | 19294695 |
MESH:D010195 |
Pancreatitis |
|
Indomethacin |
3.15 | 15028970 17883296 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
2.89 | 11578682 |
MESH:D010212 |
Papilloma |
|
Hydrogen Peroxide |
11.02 | 12065085 |
MESH:D010212 |
Papilloma |
|
Plant Extracts |
11.02 | 15173996 16517061 |
MESH:D010212 |
Papilloma |
|
Tetradecanoylphorbol Acetate |
11.02 | 18922899 12065085 18404319 8330346 |
MESH:D010257 |
Paraneoplastic Syndromes |
|
Indomethacin |
4.85 | 16537180 |
MESH:D010300 |
Parkinson Disease |
|
Dieldrin |
4.76 | 11181820 11445065 17291500 16809432 16112328 |
MESH:D010300 |
Parkinson Disease |
|
Sirolimus |
4.76 | 19682553 |
MESH:D020734 |
Parkinsonian Disorders |
|
Indomethacin |
3.37 | 12349958 |
MESH:D051302 |
Paroxysmal Hemicrania |
|
Indomethacin |
4.85 | 11903285 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
3.38 | 12520081 |
MESH:D010437 |
Peptic Ulcer |
|
Indomethacin |
4.30 | 11148446 |
MESH:D010518 |
Periodontitis |
|
Indomethacin |
4.05 | 17225004 |
MESH:D010538 |
Peritonitis |
|
Ozone |
3.31 | 16369182 |
MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
4.29 | 17983394 |
MESH:D010900 |
Pituitary Diseases |
|
Diethylstilbestrol |
4.30 | 14722030 |
MESH:D010911 |
Pituitary Neoplasms |
|
Diethylstilbestrol |
3.84 | 15687265 16977796 |
MESH:D010995 |
Pleural Diseases |
|
Asbestos, Crocidolite |
4.06 | 10923243 |
MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
4.29 | 17638057 |
MESH:D011014 |
Pneumonia |
|
Lipopolysaccharides |
8.30 | 12224865 11605937 |
MESH:D011014 |
Pneumonia |
|
Ozone |
8.30 | 18381685 18929643 18007984 |
MESH:D011041 |
Poisoning |
|
Mustard Gas |
3.03 | 15727166 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
2.75 | 18163543 |
MESH:D047928 |
Premature Birth |
|
Indomethacin |
4.29 | 17000239 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Diethylstilbestrol |
11.46 | 17184923 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
resveratrol |
11.46 | 16679765 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
11.46 | 11118676 11399792 11896295 11222880 |
MESH:D055728 |
Primary Myelofibrosis |
|
decitabine |
9.67 | 17616702 |
MESH:D055728 |
Primary Myelofibrosis |
|
trichostatin A |
9.67 | 17616702 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
8.29 | 20887781 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Testosterone |
8.29 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
bicalutamide |
11.59 | 18487222 19240160 15638997 17914592 19011039 |
MESH:D011471 |
Prostatic Neoplasms |
|
celecoxib |
11.59 | 17908994 15570007 |
MESH:D011471 |
Prostatic Neoplasms |
|
Diethylstilbestrol |
11.59 | 15046698 17136230 15846301 |
MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
11.59 | 15749863 15897917 16888761 16729912 16868541 18437689 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
11.59 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Genistein |
11.59 | 15378649 15256057 16925846 |
MESH:D011471 |
Prostatic Neoplasms |
|
Heptachlor |
11.59 | 12661182 |
MESH:D011471 |
Prostatic Neoplasms |
|
Hyaluronic Acid |
11.59 | 16864594 |
MESH:D011471 |
Prostatic Neoplasms |
|
Lindane |
11.59 | 12661182 14688026 |
MESH:D011471 |
Prostatic Neoplasms |
|
lycopene |
11.59 | 17337101 15084515 |
MESH:D011471 |
Prostatic Neoplasms |
|
Methylnitrosourea |
11.59 | 15682402 12376480 |
MESH:D011471 |
Prostatic Neoplasms |
|
methylselenic acid |
11.59 | 16205645 |
MESH:D011471 |
Prostatic Neoplasms |
|
Plant Extracts |
11.59 | 14666653 17804756 |
MESH:D011471 |
Prostatic Neoplasms |
|
resveratrol |
11.59 | 17804756 17636462 17675339 17718901 16731767 15767336 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
11.59 | 16039940 |
MESH:D011471 |
Prostatic Neoplasms |
|
Sodium Selenite |
11.59 | 18760546 |
MESH:D011471 |
Prostatic Neoplasms |
|
sulindac sulfone |
11.59 | 15570007 17908994 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
11.59 | 15067354 |
MESH:D011471 |
Prostatic Neoplasms |
|
trichostatin A |
11.59 | 19789329 18798265 |
MESH:D011471 |
Prostatic Neoplasms |
|
vorinostat |
11.59 | 17218635 |
MESH:D011507 |
Proteinuria |
|
Indomethacin |
3.38 | 11849393 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
6.74 | 15861022 16919318 |
MESH:D011537 |
Pruritus |
|
Mustard Gas |
6.74 | 18058305 |
MESH:D011595 |
Psychomotor Agitation |
|
Haloperidol |
4.13 | 11575062 |
MESH:D011618 |
Psychotic Disorders |
|
Clozapine |
6.97 | 15331141 |
MESH:D011618 |
Psychotic Disorders |
|
Haloperidol |
6.97 | 11575062 |
MESH:D011654 |
Pulmonary Edema |
|
Isoproterenol |
4.39 | 10903255 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Asbestos, Crocidolite |
7.02 | 17322281 17975199 17365031 15814490 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Mustard Gas |
7.02 | 17894541 10334151 17266442 17620002 17720292 |
MESH:D011658 |
Pulmonary Fibrosis |
|
troglitazone |
7.02 | 18162602 |
MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
3.40 | 17922066 |
MESH:D051436 |
Renal Insufficiency, Chronic |
|
resveratrol |
4.72 | 16325855 |
MESH:D015427 |
Reperfusion Injury |
|
resveratrol |
2.78 | 16314181 16317513 15827377 17520802 17058453 |
MESH:D012120 |
Respiration Disorders |
|
Chlorine |
4.35 | 18579056 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Oxygen |
3.73 | 17627322 18339021 |
MESH:D012127 |
Respiratory Distress Syndrome, Newborn |
|
Vitamin A |
4.95 | 16877224 |
MESH:D012130 |
Respiratory Hypersensitivity |
|
Lipopolysaccharides |
3.12 | 10835634 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.02 | 18990726 |
MESH:D012162 |
Retinal Degeneration |
|
Methylnitrosourea |
3.74 | 18172121 18155124 |
MESH:D012175 |
Retinoblastoma |
|
Methylnitrosourea |
4.64 | 11555667 |
MESH:D012208 |
Rhabdomyosarcoma |
|
decitabine |
3.61 | 19155313 |
MESH:D012509 |
Sarcoma |
|
Doxorubicin |
3.24 | 17203757 15675481 17710206 18313854 15625365 16767912 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
3.44 | 16326096 14601052 |
MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
3.94 | 17846226 |
MESH:D012559 |
Schizophrenia |
|
Clozapine |
3.44 | 19369910 18806925 20168265 11763009 20521320 18855531 17123785 20521326 17667964 20580759 16141801 17726453 11151749 20452607 20107430 |
MESH:D012559 |
Schizophrenia |
|
Haloperidol |
3.44 | 19369910 1830565 18513383 20107430 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
9.14 | 18551238 |
MESH:D012640 |
Seizures |
|
Endosulfan |
9.14 | 7539098 10698677 |
MESH:D012640 |
Seizures |
|
Lindane |
9.14 | 7539098 12842176 15475178 |
MESH:D012640 |
Seizures |
|
Lithium |
9.14 | 19660546 |
MESH:D012735 |
Sexual Dysfunction, Physiological |
|
Testosterone |
5.34 | 16631401 |
MESH:D012772 |
Shock, Septic |
|
lipoteichoic acid |
5.25 | 19573522 |
MESH:D012852 |
Sinusitis |
|
Phenylephrine |
3.86 | 7327846 |
MESH:D012851 |
Sinus Thrombosis, Intracranial |
|
Heparin |
5.22 | 12269725 |
MESH:D012871 |
Skin Diseases |
|
Mustard Gas |
4.30 | 12880345 16961503 15451306 |
MESH:D012871 |
Skin Diseases |
|
Vitamin A |
4.30 | 18709164 |
MESH:D012878 |
Skin Neoplasms |
|
deguelin |
23.44 | 16041863 |
MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
23.44 | 15692506 |
MESH:D012878 |
Skin Neoplasms |
|
Hydrogen Peroxide |
23.44 | 12065085 |
MESH:D012878 |
Skin Neoplasms |
|
Plant Extracts |
23.44 | 16517061 15173996 |
MESH:D012878 |
Skin Neoplasms |
|
resveratrol |
23.44 | 15837718 8985016 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
23.44 | 19524636 18572023 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
23.44 | 16192470 |
MESH:D012878 |
Skin Neoplasms |
|
Tetradecanoylphorbol Acetate |
23.44 | 12065085 8985016 8330346 11807781 18404319 |
MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
3.74 | 17203757 15625365 16767912 |
MESH:D013088 |
Spermatocele |
|
Diethylstilbestrol |
15.17 | 16002989 16709447 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
15.17 | 16709447 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
15.17 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
3.19 | 19457130 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
3.11 | 12854658 |
MESH:D013226 |
Status Epilepticus |
|
Lithium |
4.92 | 19430551 19951488 19570321 |
MESH:D013272 |
Stomach Diseases |
|
Indomethacin |
3.58 | 15038085 16113693 10215738 18545984 10486359 10192188 15472012 17638125 17160473 16280098 17207306 16184426 18209964 |
MESH:D013274 |
Stomach Neoplasms |
|
celecoxib |
4.91 | 15609394 |
MESH:D013274 |
Stomach Neoplasms |
|
decitabine |
4.91 | 19037991 |
MESH:D013274 |
Stomach Neoplasms |
|
Indomethacin |
4.91 | 15609394 |
MESH:D013274 |
Stomach Neoplasms |
|
Methylnitrosourea |
4.91 | 18593901 15930296 16257854 |
MESH:D013274 |
Stomach Neoplasms |
|
troglitazone |
4.91 | 15930296 |
MESH:D013276 |
Stomach Ulcer |
|
Indomethacin |
5.23 | 16169175 15255614 17627676 11729361 10750652 18299717 18431645 11595431 18543354 18209962 10423059 18087811 10878458 11595415 1323529 11523592 16631530 15104355 11906479 16252198 16397915 12500499 15138204 18181030 16150113 12467913 12077510 12787963 17918041 14567935 17895592 18237397 16755016 18726076 17135157 17654042 17977527 11145282 18193104 12498302 16934674 17657623 |
MESH:D013276 |
Stomach Ulcer |
|
Plant Extracts |
5.23 | 17135157 15255614 18237397 12787963 18193104 |
OMIM:601367 |
STROKE, ISCHEMIC |
|
resveratrol |
3.72 | 16321402 |
MESH:D013398 |
Sudden Infant Death |
|
Oxygen |
4.70 | 12563064 |
MESH:D017180 |
Tachycardia, Ventricular |
|
Haloperidol |
3.90 | 20210726 |
MESH:D013705 |
Temporomandibular Joint Disorders |
|
Plant Extracts |
10.41 | 17997062 |
MESH:D013705 |
Temporomandibular Joint Disorders |
|
polyphenols |
10.41 | 17997062 |
MESH:D013742 |
Tetanus |
|
Propofol |
5.57 | 2903605 |
MESH:D013921 |
Thrombocytopenia |
|
Heparin |
12.15 | 16651880 16893407 |
MESH:D013921 |
Thrombocytopenia |
|
Lipopolysaccharides |
12.15 | 15821434 |
MESH:D013921 |
Thrombocytopenia |
|
vorinostat |
12.15 | 20479100 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
2.83 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
7.05 | 15669648 |
MESH:D013927 |
Thrombosis |
|
Heparin |
7.05 | 16893407 |
MESH:D013953 |
Thymus Neoplasms |
|
Methylnitrosourea |
4.38 | 11418001 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.04 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide |
19.34 | 16940797 |
MESH:D013964 |
Thyroid Neoplasms |
|
Butyrates |
19.34 | 17967635 |
MESH:D013964 |
Thyroid Neoplasms |
|
decitabine |
19.34 | 17967635 |
MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
19.34 | 16010429 17909728 |
MESH:D013964 |
Thyroid Neoplasms |
|
Indomethacin |
19.34 | 18791128 14736730 11352223 |
MESH:D013964 |
Thyroid Neoplasms |
|
Methylnitrosourea |
19.34 | 3078959 7505956 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
3.82 | 19048282 |
MESH:D014062 |
Tongue Neoplasms |
|
resveratrol |
3.46 | 16227395 |
MESH:D014402 |
Tuberous Sclerosis |
|
Sirolimus |
4.75 | 18495876 21115397 |
MESH:D014456 |
Ulcer |
|
Indomethacin |
4.05 | 17380554 10574470 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
14.26 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
decitabine |
14.26 | 17616700 19087683 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Diethylstilbestrol |
14.26 | 16712894 16452187 17306315 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
14.26 | 17653716 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
14.26 | 17306315 11723127 16452187 16712894 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
14.26 | 16712894 8653321 17572228 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
3.47 | 10091137 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Diethylstilbestrol |
11.60 | 16175088 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
resveratrol |
11.60 | 17473185 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
11.60 | 11813266 |
MESH:D014591 |
Uterine Diseases |
|
Diethylstilbestrol |
4.30 | 14652134 |
MESH:D014594 |
Uterine Neoplasms |
|
celecoxib |
21.54 | 18645019 |
MESH:D014594 |
Uterine Neoplasms |
|
Diethylstilbestrol |
21.54 | 16690809 15809267 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
21.54 | 14692618 |
MESH:D014594 |
Uterine Neoplasms |
|
resveratrol |
21.54 | 17044934 |
MESH:D014594 |
Uterine Neoplasms |
|
sulindac sulfide |
21.54 | 18645019 |
MESH:D014604 |
Uveal Neoplasms |
|
decitabine |
4.05 | 17785578 |
MESH:D014605 |
Uveitis |
|
Sirolimus |
4.77 | 1336536 |
MESH:D014625 |
Vaginal Neoplasms |
|
Diethylstilbestrol |
3.61 | 16513791 16002989 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
3.58 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
3.73 | 12125929 |
MESH:D014657 |
Vasculitis |
|
Heparin |
5.22 | 20337814 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
2.77 | 14671159 15869587 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
17.74 | 17678736 17638931 17334414 16364871 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Isoproterenol |
17.74 | 18097624 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Plant Extracts |
17.74 | 18097624 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
resveratrol |
17.74 | 17488730 |
MESH:D020257 |
Ventricular Remodeling |
|
Isoproterenol |
10.05 | 18097624 |
MESH:D020257 |
Ventricular Remodeling |
|
Plant Extracts |
10.05 | 18097624 |
MESH:D014802 |
Vitamin A Deficiency |
|
Vitamin A |
4.48 | 16175781 16146918 16960172 |
MESH:D014839 |
Vomiting |
|
Indomethacin |
3.89 | 11897121 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
3.38 | 15886252 |
MESH:D015430 |
Weight Gain |
|
Clozapine |
3.73 | 17502770 20521320 20107430 16141801 20564506 16402076 |
MESH:D015431 |
Weight Loss |
|
Clozapine |
4.23 | 17933447 |
MESH:D014947 |
Wounds and Injuries |
|
Plant Extracts |
3.54 | 20213670 19894650 |